Login

The CEO of Freenet AG discusses the company's strategic ambitions in an interview 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Fred Hu Discusses China's Economic Recovery and Future Growth Prospects | Fred Hu, CEO, Primavera Capital Group.
00:10:00
Kevin Mahn, CIO of Hennion & Walsh Asset Management, shares insights on market trends in a CNBC interview.
00:10:00
CEO of Abitibi Royalties Ian Ball outlines goals for 2015 | Ian Ball, CEO, Abitibi Royalties Inc
00:10:00
Krsnaa Diagnostics Ltd. IPO: A Deep Dive into the Company’s Business and Financials | Yash Mutha, Director ,Krsnaa Diagnostics Ltd.
00:10:00
360° Immersion: CEO Georg Kapsch's Inspiring Address at Kapsch Factory1 Winner's Ceremony | Georg Kapsch - CEO of Kapsch TrafficCom AG
00:00:00
Sarah J. Chalmers, M.D. Critical Care Specialist, Mayo Clinic / Ask Mayo Clinic: Cystic Fibrosis
00:10:00
Multilaser Unveils New Generation of Multilaser H and Connected Homes, in Partnership with Nokia | Alexandre Ostrowiecki ,CEO, Multilaser Industrial SA.
00:10:00
Gravity Doesn't Apply Here: New Orbits for Venture Capital|Salil Deshpande,Investor, Uncorrelated
00:10:00
Paul Ryan on Health Care Reform and the Flaws of Obamacare
00:10:00
Nighthawk Gold Corp: Developing Canada's Next Premier Gold District
00:10:00
A comprehensive interview with Perfect Corp's Chief Strategy Officer, Louis Chen, discussing strategic brand partnerships and future plans.
00:10:00
Resilience of Cities Amidst Crisis: Upholding the Enduring Vitality of Urban Centers in the Face of Market Shifts| Marnix Galle, CEO, Compagnie Immobiliere de Belgique.

© 2017 - Neuhu+